We have analyzed the clinical, analytical and evolutive data of 14 cas
es of systemic mastocytosis (SM) diagnosed in our hospital between 199
1-1996 and we have compared these results with those of other publishe
d series. Clinical parameters, analytical profiles, peripheral hematol
ogic data, radiologic data and histological study were collected. Foll
owing Metcalfe's criteria, the patients were clasified in 4 groups: a)
group 1, indolent mastocytosis; b) group 2, hematologic disorders; c)
group 3, aggressive lymphadenopathic mastocytosis with eosinophilia,
and dl group 4, mastocytic leukemia. The average age at diagnosis was
52.4 years, range 25-83, and 64% were females. The mean follow-up was
2 yr. In most of the cases (71.4%) the initial complaint was urticaria
pigmentosa. The predominant clinical features were pruriginous-eritem
atous skin lesions (in 11 cases), and digestive symptoms (in 10 patien
ts). The most usual biochemical disorder was the rise of serum alkalin
e phosphatase level (in 8 patients), while lactate-dehydrogenase (LDH)
was normal in all the cases. The most striking roentgenologic feature
s were oteopenia, observed in 50% of our patients. Pheripherical hemat
ological disorders were discovered in 8 patients (64.3%) and in one of
them circulating mast-cells were observed. The bone marrow was involv
ed in all patients (100%) and in two of them mielodysplasic features w
ere found. The diagnostic of SM is difficult in the absence of skin le
sions. The skin lesions are very common in systemic mastocytosis. Bone
marrow involvement is constant, so its study has a high diagnostic re
ntability.